Incyte today announced the appointment of Dr. Dashyant Dhanak, Ph.D. as executive vice president and chief scientific officer, effective December 10, 2018. Dhanak will succeed Dr. Reid Huber, who has […]
"Reid's decision to pursue a different career path has given us the opportunity to recruit a new leader for our discovery team, and Dash brings an ideal mix of discovery and development experience into what I believe is the most innovative and productive group in the industry."
Dhanak joins Incyte from Janssen Research & Development, where he most recently served as Global Head, Discovery Sciences, leading an organization responsible for supporting and enabling the discovery and early development of novel therapeutics. Prior to Janssen, Dr. Dhanak spent 25 years at GlaxoSmithKline.